NEW YORK, October 08, 2025--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates ("Broadwood" or "we") today announced that Glass, Lewis & Co., LLC ("Glass Lewis"), a leading independent proxy ...

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on the recent Current Report on Form 8-K filed by STAAR Surgical Company (“STAAR” or the ...

Broadwood Cautions STAAR’s Board Against Making Further Significant Decisions Without Robust Shareholder Involvement and Alignment After Mounting Opposition to the Deal NEW YORK, October 15, ...

The letter is part of Broadwood’s ongoing effort to block the transaction, arguing that STAAR Surgical is "far more valuable than $28 per share" and has "bright prospects." Based on a press release ...

NEW YORK - Broadwood Partners, which owns 27.5% of STAAR Surgical Company (NASDAQ:STAA), has called on the company’s board to proceed with the scheduled October 23 shareholder vote on Alcon Inc.’s ...

Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (“STAAR” or the “Company”) ...

Dear Members of the Board: You have decided it is time to sell STAAR for $28 per share. As you know, we strongly disagree with that decision. One thing we can surely agree on, however, is that this ...

Dear Members of the Board: With incomplete information and after a poorly designed process, you decided to sell STAAR to Alcon for a woefully inadequate price. We have told you we disagree with that ...

Broadwood Partners and its affiliates issued the following letter to the Board of Directors of STAAR Surgical Company (STAA). Broadwood, which owns 27.5% of STAAR’s outstanding common shares, urges ...

Oct 15 (Reuters) - Proxy advisory firm Institutional Shareholder Services on Wednesday recommended that investors in Staar Surgical (STAA.O), opens new tab reject an offer by Swiss eyecare giant Alcon ...